Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Basware BAS1V Jun 2, 2020 31.60 +2.60   
 BBS-Bioactive Bone Substitutes BONEH Jun 2, 2020 7.75 -4.32   
 Bilot Plc BILOT Jun 2, 2020 6.90 0.00   
 Biohit B BIOBV Jun 2, 2020 2.69 +0.37   
 Bittium BITTI Jun 2, 2020 6.23 +1.14   
 CapMan CAPMAN Jun 2, 2020 1.96 +4.25   
 Cargotec CGCBV Jun 2, 2020 20.74 +3.29   
 Caverion CAV1V Jun 2, 2020 6.23 +2.81   
 Citycon CTY1S Jun 2, 2020 6.35 +2.75   
 Componenta CTH1V Jun 2, 2020 0.07 0.00   
 Consti Plc CONSTI Jun 2, 2020 6.60 0.00   
 Cramo CRA1V Jun 2, 2020 13.65 0.00   
 Detection Technology DETEC Jun 2, 2020 20.00 +1.27   
 Digia DIGIA Jun 2, 2020 5.14 +1.98   
 Digitalist Group DIGIGR Jun 2, 2020 0.03 -0.57   
 Dovre Group DOV1V Jun 2, 2020 0.25 +2.08   
 EAB Group EAB Jun 2, 2020 1.80 +2.86   
 Efecte PLC EFECTE Jun 2, 2020 5.20 +1.96   
 Elecster A ELEAV Jun 2, 2020 6.90 0.00   
 Elisa ELISA Jun 2, 2020 54.60 -3.09   
 Endomines ENDOM Jun 2, 2020 0.59 -2.30   
 Endomines ENDO Jun 2, 2020 6.28 -0.95   
 Enedo Plc ENEDO Jun 2, 2020 2.11 -6.05   
 eQ EQV1V Jun 2, 2020 14.60 +2.82   
 Ericsson B ERIBR Jun 2, 2020 8.36 +0.50   
 Etteplan ETTE Jun 2, 2020 9.00 +2.27   
 Evli Pankki EVLI Jun 2, 2020 9.06 +0.44   
 Exel Composites EXL1V Jun 2, 2020 5.24 +2.34   
 F-Secure FSC1V Jun 2, 2020 3.03 -1.78   
 Fellow Finance Oyj FELLOW Jun 2, 2020 2.48 +6.44   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK